|Articles|October 15, 2018

Latest Business and People News

Updated employee announcements, business news, awards, and recognition in the industry today.

People News

Synteract, a full-service CRO, has added two new members, Lisa Dilworth as Vice President, Rare and Orphan Diseases, and Elisabeth Schrader as Executive Director, Program Strategy, Pediatrics and Rare Diseases, to its Rare and Orphan Diseases Center of Development.

Elligo Health Research, an integrated research organization, has added Dan Pucci, MBA, as Vice President of Strategic Partnerships, and Michael A. Ibara, Pharm.D., as Vice President of Data Sciences, to its executive leadership team.

CluePoints, a provider of RBM and data quality oversight solutions for clinical trials, has announced the appointment of Richard Davies as VP, Solutions Expert, and Suzanne Lukac as Senior Account Director to its senior team.

 

The International Biomedical Research Alliance, a non-profit organization that provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, announced that Ralph A. Korpman, MD, is joining the Alliance’s Board of Directors.

The Patient Experience Project (PEP), an EVERSANA™ agency, has announced the addition of Kristen Scannell as a Patient Experience Coordinator.

Data Cubed, a healthcare technology company, hired David Kiger, as Chief Commercial Officer to expand gamification, human, and virtual clinical trial solutions.

 

 

 

Business News

MMS, a global data-focused CRO, announced a volunteer initiative to pledge more than $250,000 in employee hours to local volunteer initiatives. The program allows colleagues to choose which organizations they want to support.

Medidata announced that more than 15,000 studies have been conducted on the Medidata Cloud, its platform for life sciences.

This year at CDISC Interchanges, where attendees are the first to hear about a number of new initiatives for CDISC, the standards organization updated its audience on its strategic plan priorities and revealed the new look, messaging, website, and multimedia tools of CDISC’s new brand.

 

Recognition

MMS Holdings Inc., a data-focused CRO, announced their support to Paratek Pharmaceuticals, Inc. for the new drug application approval and successful marketing authorization application filing of NUZYRA™ for the treatment of adults with community-acquired bacterial pneumonia and acute skin and skin structure infections.

Gartner Inc., a research and advisory company, named Data Cubed as one of the “Cool Companies” in Data-Driven Health Platforms.


Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.